AstraZeneca may have given incomplete data from latest Covid trial: US agency

The Data and Safety Monitoring Board has notified the drugmaker, NIAID and the Biomedical Advanced Research and Development Authority that it was concerned by the information released by AstraZeneca on the initial data from its clinical trial